Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 12;25(4):49-58.
doi: 10.5693/djo.01.2019.08.002. eCollection 2019 Apr.

The current state of retinopathy of prematurity in India, Kenya, Mexico, Nigeria, Philippines, Romania, Thailand, and Venezuela

Theodore Bowe  1   2 , Lily Nyamai  3 , Dupe Ademola-Popoola  4 , Atchara Amphornphruet  5 , Rachelle Anzures  6 , Linda A Cernichiaro-Espinosa  7 , Roseline Duke  8 , Fahir Duran  9 , Maria Ana Martinez-Castellanos  6 , Prabhujot Kaur Multani  10 , Cristina E Nitulescu  11 , Tapas Ranjan Padhi  10 , Boontip Tipsuriyaporn  1   2   12 , R V Paul Chan  13 , J Peter Campbell  14 , Yoshihiro Yonekawa  15
Affiliations
Review

The current state of retinopathy of prematurity in India, Kenya, Mexico, Nigeria, Philippines, Romania, Thailand, and Venezuela

Theodore Bowe et al. Digit J Ophthalmol. .

Abstract

Retinopathy of prematurity (ROP) is one of the leading causes of preventable blindness in children worldwide. Middle-income nations are currently experiencing epidemic levels of ROP, because greater access to neonatal intensive care units has improved survival rates of premature infants, but without sophisticated oxygen regulation. The epidemiology, screening infrastructure, treatment options, and challenges that these countries face are often tied to unique local socioeconomic, cultural, geopolitical, and medical factors. We present an overview and narratives of the current state of ROP in eight countries that are or soon will be experiencing ROP epidemics-India, Kenya, Mexico, Nigeria, Phillipines, Romania, Thailand, and Venezuela-with a view to fostering both an understanding of the differences in the ROP landscape in various settings and an interest in the further development of ROP screening and treatment services tailored to local requirements.

PubMed Disclaimer

References

    1. Philip AGS. The evolution of neonatology. Pediatr Res. 2005;58:799–815. - PubMed
    1. Michaelson IC. The mode of development of the vascular system of the retina with some observations on its significance for certain retinal disorders. Trans Ophthalmol Soc UK. 1948;68:137–80.
    1. Ashton N, Ward B, Serpell G. Role of oxygen in the genesis of retrolental fibroplasia: a preliminary report. Br J Ophthalmol. 1953;37:513–20. - PMC - PubMed
    1. Patz A, Eastham A, Higginbotham DH, Kleh T. Oxygen studies in retrolental fibroplasia. II. The production of the microscopic changes of retrolental fibroplasia in experimental animals. Am J Ophthalmol. 1953;36:1511–22. - PubMed
    1. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia: a clinical approach. Med J Aust. 1951;2:48–50. - PubMed

LinkOut - more resources